IHS Chemical Week

Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals

Daiichi Sankyo to Buy Majority Stake in Ranbaxy

11:56 AM MDT | June 16, 2008 | Deepti Ramesh with Alex Scott

Ranbaxy Laboratories Ltd. (Gurgaon, India), India’s largest pharmaceutical company, says it has signed a share purchase and subscription agreement with Daiichi Sankyo (Tokyo), under which Daiichi will acquire a 34.8% share of Ranbaxy from the Singh family. Daiichi Sankyo is also seeking to buy a further 20% stake in Ranbaxy from ordinary shareholders. The Japanese pharma firm will pay a total of $3.4 billion-$4.6 billion for the stakes, depending on the cost of the ordinary shares. The total transaction values Ranbaxy at about $8.5 billion. The deal is...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa